Cadrenal Therapeutics CVKD Ratios (2022-2026)

NASDAQ CVKD
$1.09 -0.03 (-2.68%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Cadrenal Therapeutics Quarterly Ratios

Periods 18 quarters
Latest Jun 2026

Cadrenal Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 2.63M4.02M6.44M8.92M7.78M6.25M5.07M7.40M9.04M6.97M5.03M4.21M3.59M4.23M
Equity AverageEquity Avg. -0.42M-0.93M-3.37M-0.74M3.62M5.96M8.22M6.94M5.09M3.70M5.43M6.78M5.21M3.52M2.74M2.27M2.94M
Invested CapitalInvested Cap. -5.51M
Leverage & Solvency
Interest Coverage RatioInterest Cover -81.94-74.83-71.82-59.43-0.00M
Debt Ratio 0.06
Times Interest Earned -81.94-74.83-71.82-59.43-0.00M
Valuation
Price to BookP/B 4.075.571.011.251.581.884.942.385.515.6310.425.797.142.53
Enterprise Value 16.53M14.47M-0.25M1.23M3.20M2.49M12.49M7.65M26.33M18.59M24.59M11.84M10.53M7.95M
Market Capitalization 16.53M17.70M8.86M9.64M9.77M7.52M16.85M17.67M33.67M24.19M28.49M15.85M12.83M10.35M
Return Ratios
Return on Capital Employed [ROCE]ROCE -302.06%-199.53%-126.79%-94.37%-74.89%-138.45%-209.03%-197.05%-439.89%
Return on Assets [ROA]ROA -257.52%-181.25%-114.02%-82.86%-62.27%-99.74%-150.11%-145.44%-279.03%
Return on Equity [ROE]ROE -201.27%-123.09%-89.88%-69.82%-122.48%-205.50%-194.61%-400.44%

Cadrenal Therapeutics Ratios API

Pull Cadrenal Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CVKD&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY